Cargando…

Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli

[Image: see text] Cell membrane chromatography (CMC) derived from pathological tissues is ideal for screening specific components acting on specific diseases from complex medicines owing to the maximum simulation of in vivo drug-receptor interactions. However, there are no pathological tissue-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaofei, Cao, Yan, Zhang, Hai, Zhu, Zhenyu, Liu, Min, Liu, Haibin, Ding, Xuan, Hong, Zhanying, Li, Wuhong, Lv, Diya, Wang, Lirong, Zhuo, Xianyi, Zhang, Junping, Xie, Xiang-Qun, Chai, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033634/
https://www.ncbi.nlm.nih.gov/pubmed/24731167
http://dx.doi.org/10.1021/ac500287e
_version_ 1782317853436805120
author Chen, Xiaofei
Cao, Yan
Zhang, Hai
Zhu, Zhenyu
Liu, Min
Liu, Haibin
Ding, Xuan
Hong, Zhanying
Li, Wuhong
Lv, Diya
Wang, Lirong
Zhuo, Xianyi
Zhang, Junping
Xie, Xiang-Qun
Chai, Yifeng
author_facet Chen, Xiaofei
Cao, Yan
Zhang, Hai
Zhu, Zhenyu
Liu, Min
Liu, Haibin
Ding, Xuan
Hong, Zhanying
Li, Wuhong
Lv, Diya
Wang, Lirong
Zhuo, Xianyi
Zhang, Junping
Xie, Xiang-Qun
Chai, Yifeng
author_sort Chen, Xiaofei
collection PubMed
description [Image: see text] Cell membrane chromatography (CMC) derived from pathological tissues is ideal for screening specific components acting on specific diseases from complex medicines owing to the maximum simulation of in vivo drug-receptor interactions. However, there are no pathological tissue-derived CMC models that have ever been developed, as well as no visualized affinity comparison of potential active components between normal and pathological CMC columns. In this study, a novel comparative normal/failing rat myocardium CMC analysis system based on online column selection and comprehensive two-dimensional (2D) chromatography/monolithic column/time-of-flight mass spectrometry was developed for parallel comparison of the chromatographic behaviors on both normal and pathological CMC columns, as well as rapid screening of the specific therapeutic agents that counteract doxorubicin (DOX)-induced heart failure from Acontium carmichaeli (Fuzi). In total, 16 potential active alkaloid components with similar structures in Fuzi were retained on both normal and failing myocardium CMC models. Most of them had obvious decreases of affinities on failing myocardium CMC compared with normal CMC model except for four components, talatizamine (TALA), 14-acetyl-TALA, hetisine, and 14-benzoylneoline. One compound TALA with the highest affinity was isolated for further in vitro pharmacodynamic validation and target identification to validate the screen results. Voltage-dependent K(+) channel was confirmed as a binding target of TALA and 14-acetyl-TALA with high affinities. The online high throughput comparative CMC analysis method is suitable for screening specific active components from herbal medicines by increasing the specificity of screened results and can also be applied to other biological chromatography models.
format Online
Article
Text
id pubmed-4033634
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-40336342015-04-14 Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli Chen, Xiaofei Cao, Yan Zhang, Hai Zhu, Zhenyu Liu, Min Liu, Haibin Ding, Xuan Hong, Zhanying Li, Wuhong Lv, Diya Wang, Lirong Zhuo, Xianyi Zhang, Junping Xie, Xiang-Qun Chai, Yifeng Anal Chem [Image: see text] Cell membrane chromatography (CMC) derived from pathological tissues is ideal for screening specific components acting on specific diseases from complex medicines owing to the maximum simulation of in vivo drug-receptor interactions. However, there are no pathological tissue-derived CMC models that have ever been developed, as well as no visualized affinity comparison of potential active components between normal and pathological CMC columns. In this study, a novel comparative normal/failing rat myocardium CMC analysis system based on online column selection and comprehensive two-dimensional (2D) chromatography/monolithic column/time-of-flight mass spectrometry was developed for parallel comparison of the chromatographic behaviors on both normal and pathological CMC columns, as well as rapid screening of the specific therapeutic agents that counteract doxorubicin (DOX)-induced heart failure from Acontium carmichaeli (Fuzi). In total, 16 potential active alkaloid components with similar structures in Fuzi were retained on both normal and failing myocardium CMC models. Most of them had obvious decreases of affinities on failing myocardium CMC compared with normal CMC model except for four components, talatizamine (TALA), 14-acetyl-TALA, hetisine, and 14-benzoylneoline. One compound TALA with the highest affinity was isolated for further in vitro pharmacodynamic validation and target identification to validate the screen results. Voltage-dependent K(+) channel was confirmed as a binding target of TALA and 14-acetyl-TALA with high affinities. The online high throughput comparative CMC analysis method is suitable for screening specific active components from herbal medicines by increasing the specificity of screened results and can also be applied to other biological chromatography models. American Chemical Society 2014-04-14 2014-05-20 /pmc/articles/PMC4033634/ /pubmed/24731167 http://dx.doi.org/10.1021/ac500287e Text en Copyright © 2014 American Chemical Society
spellingShingle Chen, Xiaofei
Cao, Yan
Zhang, Hai
Zhu, Zhenyu
Liu, Min
Liu, Haibin
Ding, Xuan
Hong, Zhanying
Li, Wuhong
Lv, Diya
Wang, Lirong
Zhuo, Xianyi
Zhang, Junping
Xie, Xiang-Qun
Chai, Yifeng
Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli
title Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli
title_full Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli
title_fullStr Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli
title_full_unstemmed Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli
title_short Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli
title_sort comparative normal/failing rat myocardium cell membrane chromatographic analysis system for screening specific components that counteract doxorubicin-induced heart failure from acontium carmichaeli
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033634/
https://www.ncbi.nlm.nih.gov/pubmed/24731167
http://dx.doi.org/10.1021/ac500287e
work_keys_str_mv AT chenxiaofei comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT caoyan comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT zhanghai comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT zhuzhenyu comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT liumin comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT liuhaibin comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT dingxuan comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT hongzhanying comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT liwuhong comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT lvdiya comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT wanglirong comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT zhuoxianyi comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT zhangjunping comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT xiexiangqun comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli
AT chaiyifeng comparativenormalfailingratmyocardiumcellmembranechromatographicanalysissystemforscreeningspecificcomponentsthatcounteractdoxorubicininducedheartfailurefromacontiumcarmichaeli